Based in Durham, North Carolina, Xilis, Inc. is a biotechnology company developing a precision oncology platform that guides treatment decisions for oncologists to improve cancer care outcomes for patients and supports drug discovery and development for pharmaceutical companies. Xilis’ proprietary MicroOrganoSpheres (MOS) are miniature patient tumors that capture the full microenvironment and heterogeneity and provide an automated and scalable solution. Using MOS, high-throughput automation, and AI-driven algorithms, Xilis is developing a Xilis Response Score™ for the clinic, enabling oncologists to make informed and timely treatment decisions. Additionally, the MOS technology is speeding up development and clinical trials of cancer drugs by enabling analysis of authentic tumor microenvironments, high-throughput preclinical modeling and clinical patient selection capabilities. We are supported in this mission by top Silicon Valley, New York and international venture firms that a Apply now and work remotely at Xilis, Inc.